Kamada (KMDA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Kamada (KMDA) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA10.42 Million ≈ $27.92K USD) by net assets (ILA265.23 Million ≈ $711.08K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Kamada - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Kamada's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Kamada (KMDA) financial obligations for a breakdown of total debt and financial obligations.

Kamada Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kamada ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jiangsu Yuxing Film Tech
SHE:300305
0.058x
Aarti Drugs Limited
NSE:AARTIDRUGS
0.104x
DB Financial Investment Co Ltd
KO:016610
-0.116x
Bhagiradha Chemicals & Industries Limited
NSE:BHAGCHEM
0.008x
Chongqing Sifang New Material Co. Ltd.
SHG:605122
N/A
Shivalik Bimetal Controls Limited
NSE:SBCL
0.042x
Thessaloniki Port Authority SA
AT:OLTH
0.031x
Sinomach General Machinery Science Technology Co Ltd
SHG:600444
0.093x

Annual Cash Flow Conversion Efficiency for Kamada (2007–2024)

The table below shows the annual cash flow conversion efficiency of Kamada from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see KMDA market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ILA259.46 Million
≈ $695.61K
ILA47.59 Million
≈ $127.60K
0.183x +937.34%
2023-12-31 ILA244.02 Million
≈ $654.21K
ILA4.32 Million
≈ $11.57K
0.018x -89.11%
2022-12-31 ILA176.02 Million
≈ $471.90K
ILA28.59 Million
≈ $76.64K
0.162x +425.62%
2021-12-31 ILA176.82 Million
≈ $474.06K
ILA-8.82 Million
≈ $-23.64K
-0.050x -146.63%
2020-12-31 ILA178.64 Million
≈ $478.92K
ILA19.11 Million
≈ $51.22K
0.107x -47.51%
2019-12-31 ILA135.32 Million
≈ $362.79K
ILA27.57 Million
≈ $73.92K
0.204x +117.11%
2018-12-31 ILA112.38 Million
≈ $301.28K
ILA10.55 Million
≈ $28.27K
0.094x +115.90%
2017-12-31 ILA89.49 Million
≈ $239.92K
ILA3.89 Million
≈ $10.43K
0.043x +52.93%
2016-12-31 ILA66.74 Million
≈ $178.94K
ILA1.90 Million
≈ $5.09K
0.028x +114.74%
2015-12-31 ILA72.51 Million
≈ $194.39K
ILA-13.98 Million
≈ $-37.48K
-0.193x -57.44%
2014-12-31 ILA80.99 Million
≈ $217.14K
ILA-9.92 Million
≈ $-26.59K
-0.122x -185.86%
2013-12-31 ILA89.97 Million
≈ $241.21K
ILA-3.85 Million
≈ $-10.33K
-0.043x +85.28%
2012-12-31 ILA28.39 Million
≈ $76.12K
ILA-8.26 Million
≈ $-22.15K
-0.291x -801.65%
2011-12-31 ILA22.67 Million
≈ $60.79K
ILA940.36K
≈ $2.52K
0.041x -89.67%
2010-12-31 ILA26.49 Million
≈ $71.01K
ILA10.63 Million
≈ $28.50K
0.401x +192.43%
2009-12-31 ILA30.15 Million
≈ $80.83K
ILA-13.09 Million
≈ $-35.10K
-0.434x +56.84%
2008-12-31 ILA12.64 Million
≈ $33.89K
ILA-12.72 Million
≈ $-34.11K
-1.006x -456.76%
2007-12-31 ILA69.57 Million
≈ $186.51K
ILA-12.57 Million
≈ $-33.71K
-0.181x --

About Kamada

TA:KMDA Israel Drug Manufacturers - Specialty & Generic
Market Cap
$371.30 Million
ILA138.49 Billion ILA
Market Cap Rank
#14043 Global
#161 in Israel
Share Price
ILA2401.00
Change (1 day)
-1.23%
52-Week Range
ILA2170.00 - ILA2870.00
All Time High
ILA3940.00
About

Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmuniza… Read more